{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:01:51Z","timestamp":1790704911110,"version":"4.1.0"},"publisher-location":"Chichester, UK","reference-count":35,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd003592","type":"reference-entry","created":{"date-parts":[[2003,11,21]],"date-time":"2003-11-21T22:14:00Z","timestamp":1069452840000},"source":"Crossref","is-referenced-by-count":81,"title":["Antidepressants for generalised anxiety disorder (GAD)"],"prefix":"10.1002","author":[{"given":"Fl\u00e1vio","family":"Kapczinski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliano JSS","family":"dos Santos Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo ABC","family":"Batista Miralha da Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo RS","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2003,4,22]]},"reference":[{"issue":"8","key":"10.1002\/14651858.CD003592-BIB1|cit1","doi-asserted-by":"crossref","first-page":"528","DOI":"10.4088\/JCP.v60n0805","article-title":"Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder","volume":"60","author":"Davidson","year":"1999","journal-title":"Journal of Clinical Psychiatry"},{"issue":"23","key":"10.1002\/14651858.CD003592-BIB2|cit2","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1001\/jama.283.23.3082","article-title":"Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder","volume":"283","author":"Gelenberg","year":"2000","journal-title":"JAMA"},{"issue":"11","key":"10.1002\/14651858.CD003592-BIB3|cit3","doi-asserted-by":"crossref","first-page":"888","DOI":"10.4088\/JCP.v62n1109","article-title":"Pattern of symptom improvement following treatment with venlafaxine XR in patients with generalized anxiety disorder","volume":"62","author":"Meoni","year":"2001","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD003592-BIB4|cit4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1192\/bjp.179.1.15","article-title":"Venlafaxine extended release (ER) in the treatment of generalized anxiety disorder","volume":"179","author":"Allgulander","year":"2001","journal-title":"British Journal of Psychiatry"},{"issue":"Suppl 5","key":"10.1002\/14651858.CD003592-BIB5|cit5","first-page":"315","article-title":"Dose-response efficacy of long-term treatment of venlafaxine extended-release in generalized anxiety disorder","volume":"9","author":"Hackett","year":"1999","journal-title":"Journal of the European College of Neuropsychopharmacology 9[Suppl 5], 315. 1999"},{"key":"10.1002\/14651858.CD003592-BIB6|cit6","series-title":"152nd Annual Meeting of the American Psychiatric Association. Washington DC, USA. 15 20th May","article-title":"A six-month evaluation of three dose levels of venlafaxine extended-released in nondepressed outpatients with GAD","author":"Hackett","year":"1999"},{"issue":"11","key":"10.1002\/14651858.CD003592-BIB7|cit7","doi-asserted-by":"crossref","first-page":"888","DOI":"10.4088\/JCP.v62n1109","article-title":"Pattern of symptom improvement following treatment with venlafaxine XR in patients with generalized anxiety disorder","volume":"62","author":"Meoni","year":"2001","journal-title":"Journal of Clinical Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD003592-BIB8|cit8","doi-asserted-by":"crossref","first-page":"350","DOI":"10.4088\/JCP.v62n0508","article-title":"Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial","volume":"62","author":"Pollack","year":"2001","journal-title":"Journal of Clinical Psychiatry"},{"issue":"11","key":"10.1002\/14651858.CD003592-BIB9|cit9","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1001\/archpsyc.1993.01820230054005","article-title":"Antidepressants for the treatment of generalized anxiety disorder. A placebo-controlled comparison of imipramine, trazodone, and diazepam","volume":"50","author":"Rickels","year":"1993","journal-title":"Archives of General Psychiatry"},{"issue":"11","key":"10.1002\/14651858.CD003592-BIB10|cit10","doi-asserted-by":"crossref","first-page":"888","DOI":"10.4088\/JCP.v62n1109","article-title":"Pattern of symptom improvement following treatment with venlafaxine XR in patients with generalized anxiety disorder","volume":"62","author":"Meoni","year":"2001","journal-title":"Journal of Clinical Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD003592-BIB11|cit11","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1176\/appi.ajp.157.6.968","article-title":"Efficacy of extended release venlafaxine in nondepressed outpatients with generalized anxiety disorder","volume":"157","author":"Rickels","year":"2000","journal-title":"American Journal of Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD003592-BIB12|cit12","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1600-0447.1997.tb09660.x","article-title":"Paroxetine efficacy in the treatment of generalized anxiety disorder","volume":"95","author":"Rocca","year":"1997","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD003592-BIB13|cit13","series-title":"39th Annual Meeting of the American College of Neuropsychopharmacology; Dec 10-14; San Juan; Puerto Rico","article-title":"Treatment outcome of children with anxiety disorders","author":"Rynn","year":"2000"},{"issue":"12","key":"10.1002\/14651858.CD003592-BIB14|cit14","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1176\/appi.ajp.158.12.2008","article-title":"Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder","volume":"158","author":"Rynn","year":"2001","journal-title":"American Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD003592-BIB15|cit15","first-page":"671","article-title":"An open trial of nefazodone in adult patients with generalized anxiety disorder","volume":"32","author":"Hedges","year":"1996","journal-title":"Psychopharmacology Bulletin"},{"issue":"3","key":"10.1002\/14651858.CD003592-BIB16|cit16","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3758\/BF03332199","article-title":"The effects of chronic treatment with amitriptyline and diazepam on electrodermal activity in neurotic outpatients","volume":"12","author":"Frith","year":"1984","journal-title":"Physiological Psychology"},{"issue":"3","key":"10.1002\/14651858.CD003592-BIB17|cit17","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/BF00431822","article-title":"The relationships between clinical response, psychophysiological variables and plasma levels of amitriptyline and diazepam in neurotic outpatients","volume":"72","author":"Johnstone","year":"1981","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD003592-BIB18|cit18","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1017\/S0033291700044081","article-title":"Neurotic Illness and its response to anxiolytic and antidepressant treatment","volume":"10","author":"Johnstone","year":"1980","journal-title":"Psychological Medicine"},{"issue":"1","key":"10.1002\/14651858.CD003592-BIB19|cit19","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1001\/archpsyc.1986.01800010081010","article-title":"Imipramine and Chlordiazepoxide in depressive and anxiety disorders","volume":"43","author":"Kahn","year":"1986","journal-title":"Archives of General Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD003592-BIB20|cit20","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1001\/archpsyc.1986.01800010070009","article-title":"Imipramine and chlordiazepoxide in depressive and anxiety disorders. I. Efficacy in depressed outpatients","volume":"43","author":"Lipman","year":"1986","journal-title":"Archives of General Psychiatry"},{"issue":"12","key":"10.1002\/14651858.CD003592-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1176\/appi.ajp.157.12.1973","article-title":"Imipramine and buspirone in treatment of patients with generalized anxiety disorder who are discontinuing long-term benzodiazepine therapy","volume":"157","author":"Rickels","year":"2000","journal-title":"American Journal of Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD003592-BIB22|cit22","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/00004714-199206000-00013","article-title":"Chlomipramine treatment for generalized anxiety disorder","volume":"12","author":"Wingerson","year":"1992","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"8","key":"10.1002\/14651858.CD003592-BIB23|cit23","first-page":"293","article-title":"Differential effects of alprazolam and imipramine in generalized anxiety disorder: somatic versus psychic symptoms","volume":"49","author":"Hoehn-Saric","year":"1988","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD003592-BIB24|cit24","volume-title":"Diagnostic and Statistical manual of mental disorders: DSM-IV","year":"1994"},{"key":"10.1002\/14651858.CD003592-BIB25|cit25","first-page":"545","article-title":"Anxiety disorders - clinical section","volume-title":"A history of clinical psychiatry","author":"Berrios","year":"1995"},{"issue":"Suppl 11","key":"10.1002\/14651858.CD003592-BIB26|cit26","first-page":"15","article-title":"Psychotherapy for generalized anxiety disorder","volume":"62","author":"Borkovec","year":"2001","journal-title":"Journal of Clinical Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD003592-BIB27|cit27","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0193-953X(05)70209-4","article-title":"Pharmacological treatment of generalized anxiety disorder","volume":"24","author":"Brawman-Mintzer","year":"2001","journal-title":"Psychiatric Clinics of North America"},{"key":"10.1002\/14651858.CD003592-BIB28|cit28","volume-title":"Cochrane Reviewers\u2019 Handbook","author":"Clarke","year":"2000"},{"key":"10.1002\/14651858.CD003592-BIB29|cit29","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.0065-1591.2000.acp29-05.x","article-title":"Venlafaxine XR in the treatment of anxiety","volume":"406","author":"Hackett","year":"2000","journal-title":"Acta Psychiatrica Scandinavica. Supplementum"},{"issue":"2","key":"10.1002\/14651858.CD003592-BIB30|cit30","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00001504-200203000-00006","article-title":"The current status of the diagnostic validity and treatment of generalized anxiety disorder","volume":"15","author":"Hunt","year":"2002","journal-title":"Current Opinion in Psychiatry"},{"key":"10.1002\/14651858.CD003592-BIB31|cit31","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1600-0447.1998.tb05960.x","article-title":"Comorbidity as a fundamental feature of generalized anxiety disorders: results form the National Comorbidity Survey (NCS)","volume":"393","author":"Judd","year":"1998","journal-title":"Acta Psychiatrica Scandinavica, Supplementum"},{"key":"10.1002\/14651858.CD003592-BIB32|cit32","first-page":"67","volume-title":"The role of diagnosis in psychiatry","author":"Kendell","year":"1975"},{"issue":"4","key":"10.1002\/14651858.CD003592-BIB33|cit33","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1176\/ajp.150.4.600","article-title":"Quality of life and psychiatric morbidity in panic disorder and generalized anxiety disorder","volume":"150","author":"Massion","year":"1993","journal-title":"American Journal of Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD003592-BIB34|cit34","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1001\/archpsyc.1994.03950050015002","article-title":"DSM-III-R generalized anxiety disorder in the national comorbidity survey","volume":"51","author":"Wittchen","year":"1994","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD003592-BIB35|cit35","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1192\/bjp.168.3.308","article-title":"Phenomenology and course of generalized anxiety disorder","volume":"168","author":"Yonkers","year":"1996","journal-title":"British Journal of Psychiatry"}],"updated-by":[{"DOI":"10.1002\/14651858.cd003592.pub2","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2016,3,10]],"date-time":"2016-03-10T00:00:00Z","timestamp":1457568000000},"record-id":"31637"},{"DOI":"10.1002\/14651858.cd003592.pub2","type":"withdrawal","label":"Withdrawal","source":"publisher","updated":{"date-parts":[[2016,3,10]],"date-time":"2016-03-10T00:00:00Z","timestamp":1457568000000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD003592\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T21:23:06Z","timestamp":1628544186000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD003592"}},"subtitle":[],"editor":[{"given":"Fl\u00e1vio","family":"Kapczinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2003,4,22]]},"references-count":35,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003592","relation":{"withdrawal":[{"id-type":"doi","id":"10.1002\/14651858.CD003592.pub2","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2003,4,22]]}}}